Tanaka, A., Furuhashi, K., Fujieda, K., Horinouchi, A., Maeda, K., Saito, S., . . . Maruyama, S. Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy. Wolters Kluwer - Lippincott Williams & Wilkins.
Chicago Style (17th ed.) CitationTanaka, Akihito, et al. Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy. Wolters Kluwer - Lippincott Williams & Wilkins.
MLA (9th ed.) CitationTanaka, Akihito, et al. Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy. Wolters Kluwer - Lippincott Williams & Wilkins.
Warning: These citations may not always be 100% accurate.